Disease/Infection News

RSS

GeoVax Labs expands its HIV/AIDS vaccine program with NIAID, NIH and HVTN

GeoVax Labs, Inc., announced today that it is expanding its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health and the HIV Vaccine Trials Network.

11 Apr 2011

Study confirms measles being under-reported

Measles is not always being reported in Germany as required by law, particularly when cases are sporadic. In this edition of Deutsches Ärzteblatt International, Annedore Mette's working group presents its conclusions.

11 Apr 2011

AHF praises CA Treasurer for urging AIDS drug companies to reduce medication costs

Today AIDS Healthcare Foundation praised California State Treasurer Bill Lockyer for sending letters to the CEOs of eight AIDS drug companies—Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead Sciences, Merck & Co., Tibotec Therapeutics and ViiV Healthcare—urging them to reduce the price of their HIV/AIDS medications for California and its AIDS Drug Assistance Program.

11 Apr 2011

Enigma initiates ML system trial in patients with influenza

Enigma Diagnostics announced today that it has commenced clinical trials for its intended point of care Enigma ML Influenza A/B detection assay. Enigma will submit its application to the U.S. Food and Drug Administration for approval of the assay in 2012.

11 Apr 2011

Study unravels how interferon-induced factors inhibit viruses

When viruses attack, one molecule more than any other fights back. Interferon triggers the activation of more than 350 genes, and despite the obvious connection, the vast majority have never been tested for antiviral properties.

11 Apr 2011

Researchers manage to grow human rhinovirus in culture using sinus tissue

Using sinus tissue removed during surgery at University of Wisconsin Hospital and Clinics, researchers at the University of Wisconsin-Madison have managed to grow a recently discovered species of human rhinovirus, the most frequent cause of the common cold, in culture.

11 Apr 2011

Synexus' Chief Medical Officer to discuss vaccine trial challenges at Washington event

Dr Glynis Neagle, Synexus' Chief Medical Officer will be discussing the challenges facing global vaccine trials at the World Vaccine Congress in Washington this week.

From AES - Accelerated Enrollment Solutions 11 Apr 2011

Viral infection likely to encourage pneumonia spread

Bacteria that cause pneumonia and meningitis are only able to spread when individuals are infected with flu, says a scientist reporting at the Society for General Microbiology's Spring Conference in Harrogate. The work could have implications for the management of influenza pandemics and could help reduce incidence of pneumococcal infections in very young children, who are more susceptible to disease.

11 Apr 2011

Merck announces interim analysis from V710 Phase II/III trial in S. aureus infection

Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.

11 Apr 2011

IDSA, U.S. health officials describe ways to respond to global threat of antimicrobial resistance

To coincide with World Health Day on Thursday, the Infectious Diseases Society of America (IDSA) released a policy paper with nine recommendations for how to control the "ever-growing threat of antimicrobial resistance," CIDRAP News reports.

11 Apr 2011

New dengue test receives FDA marketing clearance

The U.S. Food and Drug Administration today allowed marketing of the first test to help diagnose people with signs and symptoms of dengue fever or dengue hemorrhagic fever, a leading cause of illness and death in the tropics and subtropics.

11 Apr 2011

SpectraShield surgical respirator receives FDA clearance to reduce MRSA infections

The U.S. Food and Drug Administration cleared the SpectraShield 9500 N95 surgical respirator, a device that kills 99.99 percent of three different kinds of bacteria when exposed to its outer surface.

11 Apr 2011

VIGILAIR air cleaning technology greatly reduces HAI in NICU: Study

VIGILAIR Systems, an industry leader in Ultraviolet Germicidal Irradiation technology was instrumental in a newly published, and first of its kind hospital study that demonstrated a dramatic reduction in patient Hospital Acquired Infections with the application of VIGILAIR® air cleaning technology in a Neonatal Intensive Care Unit.

11 Apr 2011

Cepheid receives FDA clearance for new assay to detect C. difficile infection

The U.S. Food and Drug Administration today cleared a test called the Cepheid Xpert C. difficile/Epi assay that is designed to rapidly detect the toxin B gene associated with Clostridium difficile infection, a cause of diarrhea that can lead to colitis, other serious intestinal conditions and death in severe cases.

11 Apr 2011

Malaria diagnosis made easy with smart phone app

Malaria kills nearly 1 million children a year, mostly in developing countries with little infrastructure and few resources. For the 9th Imagine Cup 2011 - a student contest sponsored by Microsoft, student entrants were asked to “imagine a world where technology helps solve the toughest problems.” Tristan Gibeau 25, a graduate computer engineering student at the University of Central Florida in Orlando and his team developed an ‘app’, LifeLens, to detect malaria.

10 Apr 2011

ViroXis' IND for EISO-derived product to treat HPV skin warts receives FDA approval

ViroXis Corporation today announced that the US Food and Drug Administration (FDA) granted approval for the Company's investigational new drug (IND) application and planned clinical development of a drug substance derived from East Indian Sandalwood oil (EISO) for the topical treatment of Human Papilloma Virus (HPV), common warts of the skin.

8 Apr 2011

Researchers test plants used in traditional African medicine against malaria

The malaria parasite has gradually developed resistance to the most commonly used medicines. To make matters worse, several mosquito species that host and transmit the parasite have become resistant to insecticides, making it difficult to eliminate them from populated areas.

8 Apr 2011

Marking World Health Day, WHO warns misuse of antibiotics undermining global fight against infectious diseases

U.N. officials on Thursday marked World Health Day with a warning that "the misuse and irrational use of antibiotics has undermined the global fight against tuberculosis and malaria, warning of a possible return to the days before the drugs were developed," and called for urgent action to control the spread of drug resistance, Reuters reports.

8 Apr 2011

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates resulted in significant reduction in lung tissue presence of leukocytes, and in particular, that of eosinophils in a lethal influenza infection animal model.

8 Apr 2011

T2 Biosystems' technology platform demonstrates ability to detect Candida organisms in whole blood samples

T2 Biosystems, Inc., a company developing next-generation diagnostic products, presented data today on the rapid and sensitive detection of five species of the fungal infection Candida at the Annual Meeting of the Mycoses Study Group in Philadelphia, PA.

8 Apr 2011

Disease/Infection News

GeoVax Labs expands its HIV/AIDS vaccine program with NIAID, NIH and HVTN

Study confirms measles being under-reported

AHF praises CA Treasurer for urging AIDS drug companies to reduce medication costs

Enigma initiates ML system trial in patients with influenza

Study unravels how interferon-induced factors inhibit viruses

Researchers manage to grow human rhinovirus in culture using sinus tissue

Synexus' Chief Medical Officer to discuss vaccine trial challenges at Washington event

Viral infection likely to encourage pneumonia spread

Merck announces interim analysis from V710 Phase II/III trial in S. aureus infection

IDSA, U.S. health officials describe ways to respond to global threat of antimicrobial resistance

New dengue test receives FDA marketing clearance

SpectraShield surgical respirator receives FDA clearance to reduce MRSA infections

VIGILAIR air cleaning technology greatly reduces HAI in NICU: Study

Cepheid receives FDA clearance for new assay to detect C. difficile infection

Malaria diagnosis made easy with smart phone app

ViroXis' IND for EISO-derived product to treat HPV skin warts receives FDA approval

Researchers test plants used in traditional African medicine against malaria

Marking World Health Day, WHO warns misuse of antibiotics undermining global fight against infectious diseases

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

T2 Biosystems' technology platform demonstrates ability to detect Candida organisms in whole blood samples

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News